SCHEMBL23928394

SCHEMBL23928394

O=[N+]([O-])c1cccc(S(=O)(=O)Nc2ccc(Br)cc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
PGR P06401 2/20 0.68
KMT2A Q03164 2/20 0.64
AR P10275 1/20 0.61
PKM P14618 1/20 0.61
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
MMP1 P03956 1/20 0.60
MMP2 P08253 1/20 0.60
MMP9 P14780 1/20 0.60
MMP8 P22894 1/20 0.60
MMP13 P45452 1/20 0.60
MEN1 O00255 1/20 0.58
DDX3X O00571 1/20 0.58
HSPD1 P10809 1/20 0.57
PTPN2 P17706 1/20 0.57
PTPN1 P18031 1/20 0.57
PTPN5 P54829 1/20 0.57
HSPE1 P61604 1/20 0.57
EDNRB P24530 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4101284 0.87 PGR (0.78) ALDH1A1PGRKMT2AARPKM
SCHEMBL15043012 0.86 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1
SCHEMBL95740 0.86 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1
SCHEMBL5233742 0.86 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1
SCHEMBL5228114 0.86 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1
SCHEMBL13970848 0.86 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1
SCHEMBL12167777 0.84 PGR (0.92) ALDH1A1PGRKMT2AARCA1
SCHEMBL14125535 0.84 CASP3 (0.76) ALDH1A1KMT2APKMMEN1LMNA
SCHEMBL29562764 0.84 CASP3 (0.76) ALDH1A1KMT2APKMMEN1LMNA
SCHEMBL5037028 0.83 ALDH1A1 (0.71) ALDH1A1PGRKMT2AARCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355597-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC) OHIO STATE INNOVATION FOUNDATION 2023-11-09 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-11660294-B2 Compounds, compositions, and methods for the treatment and prevention of avian pathogenic E. coli (APEC) OHIO STATE INNOVATION FOUNDATION (US) 2023-05-30 US disclosed
US-20210330655-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC) OHIO STATE INNOVATION FOUNDATION 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 ALDH1A1 2569/4885PGR 3572/4885KMT2A 4864/4885
US-20230355597-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC) FABP2, APC, AP1G1 ALDH1A1 2256/4885PGR 4517/4885KMT2A 4473/4885
US-11660294-B2 Compounds, compositions, and methods for the treatment and prevention of avian pathogenic E. coli (APEC) FABP2, APC, AP1G1 ALDH1A1 2256/4885PGR 4517/4885KMT2A 4473/4885
US-20210330655-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC) FABP2, APC, AP1G1 ALDH1A1 2256/4885PGR 4517/4885KMT2A 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.